Paediatric Oncology is a branch of Hematology and Oncology that deals with the diagnosis, treatment, and management of cancers in children and adolescents. Childhood cancer is a rare disease, accounting for only 1% of all cancers worldwide. However, it remains a serious public health concern, and early diagnosis and treatment are key to improving outcomes.
The most common types of childhood cancer include leukemia, lymphomas, brain and spinal cord tumours, neuroblastoma, and Wilms tumour. Treatment options for paediatric cancer include chemotherapy, radiation therapy, and surgery, among others. Combination therapies are often used to achieve the best possible outcomes for the young patients.
Research in Paediatric Oncology aims to identify new therapeutic targets and strategies to improve the survival rate and quality of life of children and adolescents with cancer. Some studies focus on understanding the biology and genetics of childhood cancers to provide more targeted and effective treatments that are specifically designed for young patients.
Ongoing paediatric oncology research also seeks to improve the long-term outcomes of childhood cancer survivors, as well as to identify ways to reduce the side effects of treatments. Research in this field is crucial for advancing the management and treatment of paediatric cancers and improving the prognosis for affected children and adolescents.
In summary, Paediatric Oncology is a critical area of research that aims to identify new therapeutic targets and treatment strategies to manage and cure cancers that affect young patients. It is an important area of hematology and oncology that requires ongoing research and funding to improve outcomes and benefit patients worldwide.